An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy	central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy	Active, not recruiting	Phase 1 / Phase 2	2026-06-15		NCT06288230

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lantu Biopharma	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Kunming Hope of Health Hospital	Kunming	China	2

Clinical trials